Ramelteon for Treatment of Adult Patients With ADHD-Related Insomnia

Summary

Primary: We hypothesize a clinically significant improvement in sleep latency, sleep-onset and total sleep time measures in adults with ADHD when given a trial of Ramelteon compared to placebo. Secondary:We expect that Ramelteon will show statistically significant improvements vs. placebo in measures of daytime sleepiness and with no decrement in daytime functioning, including such specific items as focus and social and occupational functioning.

Timeline

Start

2008-02

Primary completion

2010-02

Completion

2010-12

Drugs

Indications